Treatment of Behçet's disease: an algorithmic multidisciplinary approach

E Alpsoy, P Leccese, G Emmi, S Ohno - Frontiers in medicine, 2021 - frontiersin.org
Behçet's disease (BD) is a chronic, relapsing inflammatory, multisystem disease of unknown
etiology. The disease has a wide clinical spectrum of mucocutaneous lesions and ocular …

Behçet disease: an update for dermatologists

E Alpsoy, BC Bozca, A Bilgic - American Journal of Clinical Dermatology, 2021 - Springer
Behçet disease (BD) is a chronic, relapsing, systemic vasculitis of unknown etiology with the
clinical features of oral and genital ulcers, cutaneous vasculitic lesions, ocular, articular …

Lower relapses rate with infliximab versus adalimumab in sight-threatening uveitis: a multicenter study of 330 patients

G Maalouf, A Andrillon, M Leclercq, P Sève… - American journal of …, 2022 - Elsevier
PURPOSE To compare the relapse rate of sight-threatening noninfectious uveitis (NIU) in
patients treated with infliximab (IFX) or adalimumab (ADA). DESIGN Observational …

Anti-TNF vs tocilizumab in refractory uveitic cystoid macular edema due to Behcet's disease. Multicenter study of 49 patients

N Barroso-García, B Atienza-Mateo… - Seminars in Arthritis and …, 2023 - Elsevier
Objective To compare the efficacy of TNF inhibitors (adalimumab (ADA) and infliximab (IFX))
vs tocilizumab (TCZ) in patients with refractory cystoid macular edema (CME) due to …

[PDF][PDF] One year in review 2021: Behçet's syndrome

G Hatemi, E Seyahi, I Fresko, R Talarico… - Clin Exp …, 2021 - clinexprheumatol.org
This review aims to provide a critical digest of the recent studies that enhance our
understanding of Behçet's syndrome by evaluating time trends, differences in disease …

Behcet's disease uveitis

M Joubert, AC Desbois, F Domont… - Journal of Clinical …, 2023 - mdpi.com
Uveitis in Behçet's disease (BD) is frequent (40% of cases) and is a major cause of
morbidity. The age of onset of uveitis is between 20 and 30 years. Ocular involvement …

The current status of biological treatment for uveitis

C Gaggiano, J Sota, S Gentileschi… - Expert Review of …, 2020 - Taylor & Francis
Introduction Noninfectious uveitis represents one of the leading causes of blindness in
developed Countries, compromising patients' quality of life and social functioning. The main …

Treatment Options in Pediatric Behçet's Disease

T Giani, AF Luppino, G Ferrara - Pediatric Drugs, 2023 - Springer
Behçet's disease is a rare and poorly understood vasculitis affecting blood vessels of all
types and sizes. Uveitis and oral and genital ulcers represent the typical clinical triad …

Immunosuppressive therapy for Vogt-Koyanagi-Harada disease: a retrospective study and review of literature

N Rahman, JCM Artiaga, K Bouras, J Luis… - Journal of Ophthalmic …, 2023 - Springer
Abstract Background Vogt-Koyanagi-Harada (VKH) disease is an idiopathic autoimmune
disease which targets melanin-containing tissues such as the uvea, meninges, ear and skin …

Pediatric uveitis: Role of the pediatrician

A Shivpuri, I Turtsevich, AL Solebo… - Frontiers in …, 2022 - frontiersin.org
The challenges of childhood uveitis lie in the varied spectrum of its clinical presentation, the
often asymptomatic nature of disease, and the evolving nature of the phenotype alongside …